IRIS
BIANCO, Cataldo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 541
EU - Europa 151
AS - Asia 136
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
SA - Sud America 1
Totale 833
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 519
IT - Italia 92
SG - Singapore 81
CN - Cina 42
GB - Regno Unito 26
CA - Canada 22
SE - Svezia 17
DE - Germania 14
IN - India 5
HK - Hong Kong 4
A2 - ???statistics.table.value.countryCode.A2??? 2
FI - Finlandia 2
TH - Thailandia 2
AU - Australia 1
EU - Europa 1
IL - Israele 1
PE - Perù 1
PK - Pakistan 1
Totale 833
Salva come PNG Salva come JPEG
Città #
Chandler 137
Singapore 53
Milan 35
Princeton 34
Santa Clara 34
Lawrence 33
Catanzaro 23
London 23
Chicago 22
Wilmington 22
Ottawa 21
Ashburn 9
Des Moines 9
Boardman 7
Munich 6
Shanghai 5
Falls Church 4
Hong Kong 4
Norwalk 4
Napoli 3
Redmond 3
Redwood City 3
Vasto 3
Wamego 3
Beijing 2
Council Bluffs 2
Guangzhou 2
Helsinki 2
Nanjing 2
Pune 2
Regensburg 2
Shenzhen 2
Siena 2
Arcene 1
Aversa 1
Bari 1
Bonn 1
Brooksville 1
Cardiff 1
Delhi 1
Esslingen am Neckar 1
Fayetteville 1
Frankfurt am Main 1
Islamabad 1
Jiaxing 1
La Canada Flintridge 1
Latina 1
Lima 1
Mountain View 1
Newport 1
Prato 1
Quanzhou 1
Rui'an 1
Saint Paul 1
San Francisco 1
Seattle 1
Seregno 1
Tappahannock 1
Toronto 1
Turin 1
Urbino 1
Uxbridge 1
Vallefiorita 1
Weifang 1
Wuxi 1
Zhenjiang 1
Totale 551
Salva come PNG Salva come JPEG
Nome #
Body Uneasiness, Eating Disorders, and Muscle Dysmorphia in Individuals Who Overexercise 56
Preclinical model in HCC: the SGK1 kinase inhibitor SI113 blocks tumor progression in vitro and in vivo and synergizes with radiotherapy. 52
The SGK1 Kinase Inhibitor SI113 Sensitizes Theranostic Effects of the 64CuCl2 in Human Glioblastoma Multiforme Cells 40
In silico identification and biological evaluation of novel selective serum/glucocorticoid-inducible kinase 1 inhibitors based on the pyrazolo-pyrimidine scaffold 38
Breast Cancer, from Biology to therapy 38
Delayed response to maintenance therapy after first-line chemotherapy in metastatic intrahepatic cholangiocarcinoma: A case report 35
COOPERATIVE ANTIPROLIFERATIVE EFFECTS OF 8-CHLORO-CYCLIC AMP AND 528 ANTIEPIDERMAL GROWTH-FACTOR RECEPTOR MONOCLONAL-ANTIBODY ON HUMAN CANCER-CELLS 33
Carcinoma mammario localmente non avanzato in pazienti anziane: valutazione della tolleranza e della risposta alla terapia radiante 33
SGK1 affects RAN/RANBP1/RANGAP1 via SP1 to play a critical role in pre-miRNA nuclear export: a new route of epigenomic regulation 32
Carotid plaque detection improves the predictve value of CHA2DS2-VASc score in patients with non-valvular atrial fibrilation: The ARAPACIS Study 31
MRNA expression of transforming growth factor  in human breast carcinomas and its activity in the effusions of breast cancer patients. 30
Zd6474, an inhibitor of VEGFR and EGFR tyrosine kinase activity in combination with radiotherapy 28
Downregulation of Rl subunit of cAMP-dependent protein kinase induces growth inhibition of human mammary epithelial cells transfonned by c-Ha-ras and c-erbB-2 protooncogenes 26
Expression of transforming growth factor  in breast cancer 26
Cooperative antitumor effect of multitargeted kinase inhibitor ZD6474 and ionizing radiation in glioblastoma 26
Antitumor activity of combined treatment of human cancer cells with ionizing radiation and anti-epidermal growth factor receptor monoclonal antibody c 225 plus type I protein kinase A antisense oligonucleotide 23
Interference with EGFR signaling:paradigm for improving radiation response in cancer treatment 23
Mechanisms of resistance to mTOR inhibitors 23
Targeted therapies and radiation for the treatment of head and neck cancer 22
Combining Immune Checkpoint Inhibitors with Anti-Angiogenic Agents 22
The molecular effects of ionizing radiations on brain cells: Radiation necrosis vs. tumor recurrence 22
SI113, a SGK1 inhibitor, potentiates the effects of radiotherapy, modulates the response to oxidative stress and induces cytotoxic autophagy in human glioblastoma multiforme cells. 21
Inhibition of Hedgehog signalling by NVP-LDE225 (Erismodegib) interferes with growth and invasion of human renal cell carcinoma cells 21
PHASE-I CLINICAL-STUDY WITH 8-CHLORO-CAMP AND EVALUATION OF IMMUNOLOGICAL EFFECTS IN CANCER-PATIENTS 20
External beam radiotherapy in bone metastatic prostate cancer::impact on patients pain relief and quality of life 18
Enhancement of antitumor activity of ionizing radiation by combined treatment with the selective epidermal growth factor receptor-tyrosine kinase inhibitor 18
Antitumor activity of ZD6126, a novel vascular-targeting agent, is enhanced when combined with ZD1839, an epidermal growth factor receptor tyrosine kinase inhibitor, and potentiates the effects of radiation in a human non-small cell lung cancer xenograft model 18
SGK1, the New Player in the Game of Resistance: Chemo-Radio Molecular Target and Strategy for Inhibition 14
Tumour microenvironment and immune evasion in EGFR addicted NSCLC: Hurdles and possibilities 14
The Current Status of Novel PET Radio-Pharmaceuticals in Radiotherapy Treatment Planning of Glioma. 13
Sphingosine analog fingolimod (FTY720) increases radiation sensitivity of human breast cancer cells in vitro 13
Repeat stereotactic radiosurgery in the management of brain metastases from NSCLC: A case report and review of the literature 12
The first breast cancer screening program in southern Italy: preliminare results from three municipalities of the Naples province 10
Synergistic antitumor activity of ZD6474, an inhibitor of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling, with gemcitabine and ionizing radiation against pancreatic cancer 9
Totale 860
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.850
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.850
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202025 0 0 0 0 0 0 0 0 0 0 3 22
2020/202160 8 0 0 5 3 9 3 0 17 2 3 10
2021/202298 1 1 0 17 8 5 4 28 10 9 13 2
2022/2023340 67 7 20 21 55 31 1 25 70 23 19 1
2023/2024111 26 16 10 6 6 28 6 3 2 1 2 5
2024/2025221 61 23 21 11 22 54 4 6 19 0 0 0
Totale 860